# VREOF earnings call intelligence LOPJLB CallCard / temporal rollup · freemium · [stock page](https://www.lopjlb.com/stock/VREOF) · [Earnings tab](https://www.lopjlb.com/stock/VREOF?tab=earnings) Updated: 2026-08-11T05:29:17 Quarters analyzed: 8 ## Cross-quarter narrative Across the earnings calls, Vireo Growth demonstrated revenue growth, improved margins, and strategic investments. The company navigated regulatory uncertainties, litigation risks, and market competition. Despite delays in New York divestiture and Minnesota adult-use launch, Vireo secured financing, closed mergers, and expanded its footprint. The narrative shifted from focusing on individual state launches to emphasizing national growth, integration, and regulatory compliance. Recent acquisitions and partnerships have positioned the company for further expansion, but integration risks, competitive pressures, and regulatory uncertainties persist. ## Latest CallCard · Q1 Vireo Growth reported transformative Q1 acquisitions, strong cash balance and expanding footprint, while highlighting integration work in Florida, weather impacts in Minnesota and cautious capex amid regulatory uncertainty. **Guidance:** vague — Management provided no specific revenue or margin guidance, only qualitative outlook. **Tone:** mgmt 0.8 · Q&A pressure 0.6 · divergence 0.2 Prepared remarks highlighted transformative acquisitions, strong cash position and outlook to deliver a strong 2026. ### Demand visibility Limited visibility; management cites strong cash and growth opportunities but provides few specifics on demand. Prepared remarks focus on acquisitions and cash, while Q&A reveals uncertainty about Florida integration and Minnesota weather impacts. ### Margins / costs Gross margin improved to 56.3% and adjusted EBITDA margin near 31%. Tyson reported gross margin 56.3% (+280 bps YoY) and adjusted EBITDA $32.7M (30.8% of sales), indicating margin expansion. ### Capital allocation Prudent capital deployment toward high‑growth acquisitions and organic investments. Management emphasized disciplined growth through accretive M&A, organic investment, and maintaining a strong cash balance of $135‑$138M. ### Milestones - **FLUENT (Florida integration)** [at_risk]: Integration of FLUENT assets in Florida underway; leadership team being identified. - **Glass House partnership** [on_track]: Partnership combines Vireo retail/delivery with Glass House production to scale in California. - **New York JV** [new]: Targeting >$100M revenue; partnership considered capable on sales side. - **Minnesota capacity expansion** [on_track]: Expect to become largest producer in Minnesota, with harvest imminent. - **Texas license sale** [delivered]: Decided to sell Texas license, citing capex and regulatory uncertainty. - **Recent acquisitions (Schwazze, Eaze, etc.)** [delivered]: Closed multiple acquisitions adding over $100M quarterly revenue. ### Fears / risks - **Integration risk**: Rapid M&A pace may strain integration capabilities across multiple states. - **Regulatory uncertainty**: Potential changes in cannabis regulations, especially in Texas and Florida, could affect investments. - **Weather risk**: Severe weather in Minnesota caused store closures, affecting sales. - **Competitive pressure**: Florida market competition may limit EBITDA upside. - **Capex discipline**: Management's aversion to high‑capex projects could limit growth opportunities. - **Market demand volatility**: Rescheduling and macro factors could impact consumer demand. - **Execution risk**: Identifying effective leadership for Florida integration is critical. - **Margin pressure**: Maintaining high EBITDA margins may be challenging as scale increases. ### Key quotes > “We now operate in 10 states with over 160 dispensaries and hold leading positions as the largest operator in Colorado, Utah and Nevada, along with meaningful market share in Minnesota and Missouri.” > “First quarter GAAP revenue of $106.2 million increased 333% year-over-year on a reported basis.” > “Florida is a massive undertaking, right? And if you think about what we're doing, we're partnering with great companies that are really good operators at the local level to minimize your first question, which is the noise around” — John Mazarakis > “I despise CapEx, especially when there's meaningful regulatory uncertainty. I like to invest in projects where the CapEx investment will be, cash-on-cash return in one year. So that's 100% cash-on-cash return.” > “our EBITDA margin is north of 60%. But again, we don't take margins to the bank, we take dollars, so we just want to make sure that we're building a company that has non-volatile cash flow going forward.” ## Quarter one-liners - **2026 Q1:** Vireo Growth reported transformative Q1 acquisitions, strong cash balance and expanding footprint, while highlighting integration work in Florida, weather impacts in Minnesota and cautious capex amid regulatory uncertainty. - **2025 Q2:** Vireo reported Q2 revenue and EBITDA in line with expectations, closed three mergers, refinanced debt, and highlighted growth prospects in Minnesota adult‑use, Nevada and Missouri while noting regulatory and pricing uncertainties. - **2025 Q1:** Vireo reported modest revenue growth, on‑track Q2 merger closures, a ramping New York wholesale operation, and expressed confidence in integration despite analyst questions on assets and regulatory timing. - **2024 Q4:** Vireo reported record $100M revenue, 51.1% gross margin and $91.6M cash, highlighted growth investments in Minnesota and New York, secured financing for a new Elk River cultivation site, and said pending 2025 mergers and adult‑use launch position the company for a transformational year. - **2024 Q3:** Vireo Growth Q3 2024 revenue rose 6.2% to $22.4M, highlighted Maryland market strength, ongoing Minnesota adult‑use prep, secured $10M financing, but faces New York divestiture delays and Verano litigation. - **2024 Q1:** Goodness Growth sees strong Maryland sales, launches Minnesota beverages, but faces timing uncertainty for Minnesota adult-use launch and ongoing Verano litigation. - **2023 Q4:** Goodness Growth reported strong Q4 revenue growth and operating profit, highlighted Maryland adult‑use launch and collaborations, but flagged delayed New York divestiture, pending credit extension, tax position uncertainty and ongoing Verano litigation. - **2023 Q3:** Goodness Growth reported 44% YoY revenue growth, highlighted Maryland adult‑use launch and operational gains, while noting New York divestiture delays, Verano litigation uncertainty, and ongoing focus on cash‑flow and credit improvement. ## Theme arcs - **Revenue Growth** (improving): Record revenue in 2024 Q4 and continued growth in subsequent quarters - **Regulatory Uncertainty** (deteriorating): Ongoing delays in New York divestiture and Minnesota adult-use launch - **Litigation Risks** (stable): Verano lawsuit remains ongoing with uncertain outcome - **Market Competition** (deteriorating): Increasing competition in New York, Nevada, and Missouri markets - **Integration and Expansion** (improving): Successful closure of mergers and strategic partnerships - **Financial Performance** (improving): Improved gross margin and adjusted EBITDA margin in recent quarters ## Fear persistence - **Regulatory Risk** [recurring]: Ongoing concerns about regulatory approvals and compliance - **Litigation Risk** [recurring]: Verano lawsuit remains ongoing with uncertain outcome - **Market Competition** [recurring]: Increasing competition in multiple markets - **Integration Risk** [new]: Recent acquisitions and partnerships introduce integration challenges - **Financial Risk** [resolved]: Improved financial performance and strong cash balance mitigate financial risks - **Weather Risk** [new]: Severe weather in Minnesota caused store closures, affecting sales ## Guidance path 2023 Q3:maintained → 2023 Q4:vague → 2024 Q1:maintained → 2024 Q3:maintained → 2024 Q4:vague → 2025 Q1:maintained → 2025 Q2:maintained → 2026 Q1:vague --- Research context only. Not personalized investment advice. API: `GET /bff/api/bigfive/earnings-intel/VREOF`